Overview

A Pilot Study of Fish Oil Supplementation in Hemodialysis Patients

Status:
Completed
Trial end date:
2006-05-01
Target enrollment:
0
Participant gender:
All
Summary
The main goal of this study is to determine whether the American Heart Association-recommended fish oil dose is efficacious, safe, and tolerable in hemodialysis patients. The secondary objective is to test the effects of fish oil supplementation on inflammatory and cardiovascular markers.
Phase:
N/A
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
Indiana University School of Medicine
Criteria
Exclusion Criteria:

1. Age <18

2. Pregnant individuals

3. Fish oil or omega-3 supplementation in past 6 months

4. Fish, corn, soybean, gelatin, or vanilla allergies

5. Currently enrolled in a dietary or investigational drug study

6. Life expectancy < 3 months

7. Ongoing active illness requiring hospitalization

8. Malabsorption syndromes

9. Chronic heparin or coumadin anticoagulation (??)

10. Active bleeding issues